Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH

Thursday, January 31, 2019

apceth Biopharma GmbH a leading contract manufacturing organization in the field of cell and gene therapy announces today that Hitachi Chemical Co Ltd will enter into an agreement to acquire all shares of apceth Biopharma GmbH This acquisition is exp...

Eureka Therapeutics Announces US FDA Clearance of IND Application for Phase 1/2 Trial of ET140202 Artemis T-Cell Therapy, for the Treatment of Liver Cancer

Thursday, January 31, 2019

Eureka Therapeutics Inc a clinical stage biotechnology company developing antibodyTCR AbTCR Tcell therapies today announced that the US Food and Drug Administration FDA has cleared its investigational new drug IND application for ET ARTEMIS Tcell the...

BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder

Thursday, January 31, 2019

BrainsWay Ltd a global leader in the advanced noninvasive treatment of brain disorders today announced that its Deep TMS System has been approved in Japan by the Pharmaceuticals and Medical Devices Agency PMDA for the treatment of patients suffering...

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife's 3F Antimicrobial Fragrance Shows Efficacy against Tuberculosis

Wednesday, January 30, 2019

Singapore Exchangelisted Singapore eDevelopment Limited Stock Code V SeD wishes to announce today that its US biomedical subsidiary Global BioLife Inc Global BioLife has a product known as F Antimicrobial Fragrance which shows efficacy against tuberc...

Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain

Wednesday, January 30, 2019

Pfizer Inc and Eli Lilly and Company today announced positive topline results from a Phase study evaluating tanezumab mg or mg in patients with moderatetosevere osteoarthritis OA pain The tanezumab mg treatment arm met all three coprimary endpoin...

Lambda Therapeutic Research Expands Global Footprint in the U.S. by Acquiring Novum Pharmaceutical Research Services

Wednesday, January 30, 2019

In a move to provide greater global reach for pharmaceutical customers and greater capabilities in the US market one of the worlds leading Contract Research Organizations CRO Lambda Therapeutic Research has reached an agreement to acquire Novum Pharm...

Kowa Pharmaceuticals America, Inc. Enters into Co-Promotion Agreement with Allergan for BYSTOLIC® (nebivolol) in the United States

Tuesday, January 29, 2019

Kowa Pharmaceuticals America Inc announced today that it has entered into an agreement with Allergan plc to copromote Allergans BYSTOLIC nebivolol a beta blocker approved for the treatment of hypertension to lower blood pressure in the United States...

8th Annual Biologics Manufacturing Korea 2019

Tuesday, January 29, 2019

Beyond Kpop and Kfood Kbiologics is set to sweep across the world According to Reports Koreas bio fever is being spurred on by the domestic development of biosimilars by firms such as Celltrion Samsung Bioepis LG Chem GC Green Cross Chong Kun Dang CJ...

Centerline Biomedical Announces FDA Submission for IOPS System

Monday, January 28, 2019

Centerline Biomedical Inc announced on January nd that the company submitted a k premarket notification application to the United States Food and Drug Administration FDA for its flagship product the IntraOperative Positioning System IOPSIOPS a no...

United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag

Friday, January 25, 2019

United Therapeutics Corporation today announced the closing of the transactions contemplated by its license agreement with Arena Pharmaceuticals Inc Under the agreement United Therapeutics acquired exclusive worldwide rights to develop and manufactur...